J. Zou, M. Rudwaleit, J. Brandt, A. Thiel, J. Braun, J. Sieper (2003)
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.Arthritis and rheumatism, 48 3
M. Bollow, T. Fischer, H. Reisshauer, M. Backhaus, J. Sieper, B. Hamm, J. Braun (2000)
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imagingAnnals of the Rheumatic Diseases, 59
C. Keller, A. Webb, J. Davis (2003)
Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature reviewAnnals of the Rheumatic Diseases, 62
H. Appel, L. Neure, M. Kuhne, J. Braun, M. Rudwaleit, J. Sieper (2004)
An elevated level of IL-10- and TGFβ-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritisClinical Rheumatology, 23
P. Claudepierre, J. Rymer, F. Authier, Y. Allanore, B. Larget-Piet, R. Gherardi, X. Chevalier (1997)
A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies.British journal of rheumatology, 36 3
J. Gratacós, A. Collado, X. Filella, R. Sanmartí, J. Cañete, J. Llena, R. Molina, A. Ballesta, J. Muñoz‐Gómez (1994)
SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITYRheumatology, 33
C. Buckley (1931)
SPONDYLITIS DEFORMANSBritish Medical Journal, 1
G. Weissmann, B. Samuelsson, R. Paoletti (1979)
Advances in inflammation research
B. Bulkley, W. Roberts (1973)
Ankylosing Spondylitis and Aortic Regurgitation: Description of the Characteristic Cardiovascular Lesion From Study of Eight Necropsy PatientsCirculation, 48
T. Smeets, E. Barg, M. Kraan, Malcolm Smith, F. Breedveld, P. Tak (2003)
Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritisAnnals of the Rheumatic Diseases, 62
P. Claudepierre, J. Rymer, X. Chevalier (1997)
IL-10 plasma levels correlate with disease activity in spondyloarthropathy.The Journal of rheumatology, 24 8
B. Vandooren, E. Kruithof, D. Yu, M. Rihl, J. Gu, L. Rycke, F. Bosch, E. Veys, F. Keyser, D. Baeten (2004)
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.Arthritis and rheumatism, 50 9
F. Mcgarry, J. Neilly, N. Anderson, R. Sturrock, M. Field (2001)
A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis.Rheumatology, 40 12
Jana Pickova (1940)
Arthritis and Allied ConditionsThe Indian Medical Gazette, 75
J. Gratacós, A. Collado, X. Filella, R. Sanmartí, J. Cañete, J. Llena, R. Molina, A. Ballesta, J. Muñoz‐Gómez (1994)
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.British journal of rheumatology, 33 10
J. Hollander (1949)
ARTHRITIS AND ALLIED CONDITIONSThe American Journal of the Medical Sciences, 218
A. Bucht, P. Larsson, L. Weisbrot, C. Thorne, P. Pisa, G. Smedegård, E. Keystone, A. Grönberg (1996)
Expression of interferon‐gamma (IFN‐δ), IL‐10, IL‐12 and transforming growth factor‐beta (TGF‐β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)Clinical & Experimental Immunology, 103
Z. Tutuncu, A. Bilgie, L. Kennedy, A. Calin (1994)
Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.Annals of the Rheumatic Diseases, 53
J. Braun, X. Baraliakos, W. Golder, J. Brandt, M. Rudwaleit, J. Listing, M. Bollow, J. Sieper, D. Heijde (2003)
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.Arthritis and rheumatism, 48 4
(1968)
A case of early ankylosing spondylitis with fatal secondary amyloidosis. Demonstrated at the Royal Postgraduate Medical School
(1967)
Röntgenanatomische Untersuchungen an Sakroiliakal-Gelenken
F. Bosch, E. Kruithof, D. Baeten, A. Herssens, F. Keyser, H. Mielants, E. Veys (2002)
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.Arthritis and rheumatism, 46 3
H. Krug (1998)
Fibroblasts from mice with progessive ankylosis proliferate excessively in response to transforming growth factor-beta 1.Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 46 4
Jürgen Braun, M. Bollow, L. Neure, E. Seipelt, F. Seyrekbasan, Hermann Herbst, U. Eggens, Armin Distler, J. Sieper (1995)
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.Arthritis and rheumatism, 38 4
E. Toussirot, P. Lafforgue, J. Boucraut, P. Despieds, A. Schiano, D. Bernard, P. Acquaviva (1994)
Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies.Rheumatology international, 13 5
J. Kehrl, L. Wakefield, A. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. Sporn, A. Fauci (1986)
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growthThe Journal of Experimental Medicine, 163
James Watson (1986)
Cytokines and their receptors.Immunology today, 7 11
M. Mercado, A. Garcia-Gonzalez, J. Muñóz-Valle, T. Garcia-Iglesias, G. Martínez-Bonilla, G. Bernard-Medina, A. Sánchez-Ortíz, José Ornelas-Aguirre, M. Salazar-Páramo, J. Gámez-Nava, L. Gonzalez-Lopez (2002)
Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis.The Journal of rheumatology, 29 3
A. Falkenbach, M. Herold (1998)
In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobilityRheumatology International, 18
J. Zou, M. Rudwaleit, J. Brandt, A. Thiel, J. Braun, J. Sieper (2003)
Up regulation of the production of tumour necrosis factor α and interferon γ by T cells in ankylosing spondylitis during treatment with etanerceptAnnals of the Rheumatic Diseases, 62
M. Rudwaleit, S. Siegert, Z. Yin, J. Eick, A. Thiel, Andreas Radbruch, J. Sieper, J. Braun (2001)
Low T cell production of TNFα and IFNγ in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphismAnnals of the Rheumatic Diseases, 60
R. François, D. Gardner, E. Degrave, E. Bywaters (2000)
Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis.Arthritis and rheumatism, 43 9
John Davis, D. Heijde, J. Braun, M. Dougados, J. Cush, D. Clegg, A. Kivitz, R. Fleischmann, R. Inman, W. Tsuji (2003)
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.Arthritis and rheumatism, 48 11
F. Houssiau, F. Houssiau, J. Devogelaer, J. Damme, C. Deuxchaisnes, J. Snick (1988)
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.Arthritis and rheumatism, 31 6
H. Weens (1970)
Handbuch der Medizinischen Radiologie, Encyclopedia of Medical Radiology.JAMA Pediatrics, 119
Andrew Timms, A. Crane, A. Sims, Heather Cordell, L. Bradbury, A. Abbott, Mark Coyne, O. Beynon, I. Herzberg, Gordon Duff, A. Calin, L. Cardon, B. Wordsworth, Matthew Brown (2004)
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis.American journal of human genetics, 75 4
E. Toussirot, P. Lafforgue, J. Boucraut, P. Despieds, A. Schiano, D. Bernard, P. Acquaviva (2004)
Serum levels of interleukin 1-β, tumor necrosis factor-α, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathiesRheumatology International, 13
F. Taketazu, Mitsuyasu Kato, Anders Gobl, Hidenori Ichijo, P. Dijke, J. Itoh, Masahisa Kyogoku, J. Rönnelid, K. Miyazono, C. Heldin, Keiko Funa (1994)
Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.Laboratory investigation; a journal of technical methods and pathology, 70 5
M. Paardt, J. Crusius, M. Garcia-Gonzalez, P. Baudoin, P. Kostense, B. Alizadeh, B. Dijkmans, A. Peña, I. Horst-Bruinsma (2002)
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis.Rheumatology, 41 12
J. Braun, M. Bollow, F. Seyrekbasan, H. Häberle, U. Eggens, A. Mertz, Armin Distler, J. Sieper (1996)
Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging.The Journal of rheumatology, 23 4
M. Lotz, J. Kekow, D. Carson (1990)
Transforming growth factor-beta and cellular immune responses in synovial fluids.Journal of immunology, 144 11
E. Jaakkola, A. Crane, K. Laiho, I. Herzberg, A. Sims, L. Bradbury, A. Calin, S. Brophy, M. Kauppi, K. Kaarela, Bryan Wordsworth, J. Tuomilehto, M. Brown (2004)
The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis.Rheumatology, 43 1
M. Rudwaleit, S. Siegert, Z. Yin, J. Eick, A. Thiel, Andreas Radbruch, J. Sieper, J. Braun (2001)
Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.Annals of the rheumatic diseases, 60 1
E. Toussirot, E. Racadot, N. Nguyen, G. Dumoulin, D. Wendling (2000)
Absence of relation between TGF beta 1 serum levels and bone mass in ankylosing spondylitis patients.Clinical and experimental rheumatology, 18 1
H. Howe, P. Cheung, K. Kong, H. Badsha, B. Thong, K. Leong, E. Koh, T. Lian, Y. Cheng, S. Lam, D. Teo, T. Lau, B. Leung (2005)
Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis.Rheumatology, 44 1
C. Chu, M. Field, S. Allard, E. Abney, M. Feldmann, R. Maini (1992)
Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.British journal of rheumatology, 31 10
S. Drynda, C. Kühne, J. Kekow (2002)
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritisAnnals of the Rheumatic Diseases, 61
D. Baeten, D. Baeten, E. Kruithof, F. Bosch, P. Demetter, N. Damme, C. Cuvelier, M. Vos, H. Mielants, E. Veys, F. Keyser (2001)
Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.Arthritis and rheumatism, 44 1
W. Dihlmann (1967)
[Critical studies on the histology of the sacroiliac joints in Bechterew's disease. (Ankylosing spondylitis)].Zeitschrift fur Rheumaforschung, 26 9
Michael Joyce, A. Roberts, M. Sporn, M. Bolander (1990)
Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femurThe Journal of Cell Biology, 110
L. Laloux, M. Voisin, J. Allain, N. Martin, L. Kerboull, X. Chevalier, P. Claudepierre, Créteil Mondor, France Laloux, Hôpital Henri, J. Mondor, Allain (2001)
Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritisAnnals of the Rheumatic Diseases, 60
(1983)
Le diagnostic précoce de la spondylarthrite ankylosante. Bases anatomo-radiologiques
J. Brandt, A. Khariouzov, J. Listing, H. Haibel, H. Sörensen, L. Grassnickel, M. Rudwaleit, J. Sieper, Jürgen Braun (2003)
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.Arthritis and rheumatism, 48 6
(1984)
Pathology of the spondylarthropathies
Jürgen Braun, M. Bollow, U. Eggens, H. König, Armin Distler, J. Sieper (1994)
Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients.Arthritis and rheumatism, 37 7
D. McGonagle, H. Marzo-Ortega, P. O'connor, W. Gibbon, P. Hawkey, K. Henshaw, P. Emery (2002)
Histological assessment of the early enthesitis lesion in spondyloarthropathyAnnals of the Rheumatic Diseases, 61
J. Zou, Y. Zhang, A. Thiel, M. Rudwaleit, Shuyu Shi, Andreas Radbruch, R. Poole, J. Braun, J. Sieper (2003)
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.Rheumatology, 42 7
M. Paardt, J. Crusius, M. Garcia-Gonzalez, P. Baudoin, P. Kostense, B. Alizadeh, B. Dijkmans, A. Peña, I. Horst-Bruinsma (2002)
Interleukin‐1β and interleukin‐1 receptor antagonist gene polymorphisms in ankylosing spondylitisRheumatology, 41
J. Zou, M. Rudwaleit, J. Brandt, A. Thiel, J. Braun, J. Sieper (2003)
Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept.Annals of the rheumatic diseases, 62 6
H. Benton (1991)
Cytokines and their receptors.Current opinion in cell biology, 3 2
G. Cassese, S. Lindenau, B. Boer, S. Arce, Anja Hauser, G. Riemekasten, C. Berek, F. Hiepe, Andreas Radbruch, R. Manz (2001)
Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytesArthritis Research, 3
Schlaak Jf, I. Pfers, M. Kh, E. Märker-Hermann (1996)
Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies.Clinical and experimental rheumatology, 14 2
D. Baeten, N. Damme, F. Bosch, E. Kruithof, M. Vos, H. Mielants, E. Veys, F. Keyser (2001)
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFαAnnals of the Rheumatic Diseases, 60
B. Kidd, K. Moore, M. Walters, J. Smith, M. Cawley (1989)
Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis.Annals of the Rheumatic Diseases, 48
(1975)
Les lésions des articulations sacro-iliaques. Le rachis dans la spondylarthrite ankylosante [dissertation
Annals of the Rheumatic Diseases – Unpaywall
Published: Oct 26, 2005
Access the full text.
Sign up today, get DeepDyve free for 14 days.